Operating Lease, Right-of-Use Asset of Dianthus Therapeutics, Inc. /DE/ from 31 Dec 2021 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Dianthus Therapeutics, Inc. /DE/ quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Dec 2021 to 30 Sep 2025.
  • Dianthus Therapeutics, Inc. /DE/ Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $1,306,000, a 271% increase year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Dianthus Therapeutics, Inc. /DE/ Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $1,306,000 +$954,000 +271% 30 Sep 2025 10-Q 05 Nov 2025 2025 Q3
Q2 2025 $1,378,000 +$936,000 +212% 30 Jun 2025 10-Q 07 Aug 2025 2025 Q2
Q1 2025 $1,447,000 +$917,000 +173% 31 Mar 2025 10-Q 12 May 2025 2025 Q1
Q4 2024 $1,553,000 +$938,000 +153% 31 Dec 2024 10-Q 05 Nov 2025 2025 Q3
Q3 2024 $352,000 -$346,000 -50% 30 Sep 2024 10-Q 07 Nov 2024 2024 Q3
Q2 2024 $442,000 +$442,000 30 Jun 2024 10-Q 08 Aug 2024 2024 Q2
Q1 2024 $530,000 +$530,000 31 Mar 2024 10-Q 09 May 2024 2024 Q1
Q4 2023 $615,000 -$199,000 -24% 31 Dec 2023 10-K 11 Mar 2025 2024 FY
Q3 2023 $698,000 -$23,232,000 -97% 30 Sep 2023 10-Q 09 Nov 2023 2023 Q3
Q2 2023 $0 -$24,670,000 -100% 30 Jun 2023 10-Q 03 Aug 2023 2023 Q2
Q1 2023 $0 -$25,389,000 -100% 31 Mar 2023 10-Q 15 May 2023 2023 Q1
Q4 2022 $814,000 +$814,000 31 Dec 2022 10-K 21 Mar 2024 2023 FY
Q3 2022 $23,930,000 30 Sep 2022 10-Q 03 Nov 2022 2022 Q3
Q2 2022 $24,670,000 30 Jun 2022 10-Q 04 Aug 2022 2022 Q2
Q1 2022 $25,389,000 31 Mar 2022 10-Q 16 May 2022 2022 Q1
Q4 2021 $0 31 Dec 2021 8-K 21 Dec 2023
* An asterisk sign (*) next to the value indicates that the value is likely invalid.